Alexander Nolte
Keine laufenden Positionen mehr
Profil
Alexander Nolte worked as Director-International Accounting at Aegerion Pharmaceuticals, Inc. from 2013 to 2015.
He then worked as Chief Accounting Officer & Vice President at Syndax Pharmaceuticals, Inc. from 2017 to 2023.
In 2023, he became the Chief Financial Officer, Treasurer & CAO at Oncorus, Inc. Mr. Nolte received an undergraduate degree from The Hague University of Applied Sciences.
Ehemalige bekannte Positionen von Alexander Nolte
| Unternehmen | Position | Ende |
|---|---|---|
| ONCORUS, INC. | Finanzdirektor/CFO | 04.08.2023 |
| SYNDAX PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.06.2022 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Alexander Nolte
| The Hague University of Applied Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ONCORUS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
